Exact Sciences shares down sharply after panel’s ruling on colon test
Shares of Exact Sciences Corp. plunged Tuesday morning after the U.S. Preventive Services Task Forceissued a preliminary recommendation, saying it considers the company's non-invasive colon cancer test as an "alternative test." The Madison company's stock dropped more than 40% in morning trading. The shares, which closed...